Corcept Therapeutics Company Profile (NASDAQ:CORT)

Analyst Ratings

Consensus Ratings for Corcept Therapeutics (NASDAQ:CORT) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.67 (83.91% upside)

Analysts' Ratings History for Corcept Therapeutics (NASDAQ:CORT)
Show:
DateFirmActionRatingPrice TargetActions
6/23/2016FBR & CoReiterated RatingOutperform$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/29/2015Piper Jaffray Cos.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2015Janney Montgomery ScottInitiated CoverageBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/31/2014 forward)

Earnings

Earnings History for Corcept Therapeutics (NASDAQ:CORT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016Q216$0.01$18.36 millionN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2016Q116$0.01$0.02$16.32 million$16.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2016Q415($0.02)$0.01$15.50 million$15.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.02)($0.01)$13.90 million$13.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215($0.04)($0.02)$11.67 million$11.96 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.04)($0.05)$10.50 million$10.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2015Q414($0.06)($0.02)$9.10 million$9.01 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q214($0.07)($0.06)$7.62 million$7.28 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q2($0.10)($0.05)$6.00 million$5.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q114($0.09)($0.11)$5.01 million$4.41 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/5/2014Q413($0.10)($0.11)$4.01 million$4.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2014Q4($0.12)($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313($0.12)($0.08)$2.70 million$2.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2013Q2 2013($0.11)($0.10)$2.72 million$1.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013($0.09)($0.10)$2.48 million$1.72 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/7/2013Q4 2012($0.09)($0.09)$1.50 million$1.38 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Corcept Therapeutics (NASDAQ:CORT)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.01$0.01$0.01
Q2 20161$0.02$0.02$0.02
Q3 20161$0.03$0.03$0.03
Q4 20161$0.04$0.04$0.04
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Corcept Therapeutics (NASDAQ:CORT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Corcept Therapeutics (NASDAQ:CORT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/10/2016G Leonard Baker JrDirectorBuy100,000$4.88$488,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/6/2016James N WilsonDirectorSell1,188$4.90$5,821.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2015Daniel BradburyDirectorSell20,000$4.85$97,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2015Daniel BradburyDirectorSell40,000$5.00$200,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2015James N WilsonDirectorSell20,000$4.90$98,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015Steven LoVPSell12,500$4.00$50,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/13/2015Steven LoVPSell53,033$3.82$202,586.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/7/2015Steven LoVPSell5,300$4.00$21,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/6/2015Steven LoVPSell50,000$3.76$188,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2015Daniel BradburyDirectorSell20,000$4.96$99,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015James N WilsonDirectorSell10,000$4.90$49,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2015Daniel BradburyDirectorSell20,000$4.76$95,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/21/2015Daniel BradburyDirectorSell10,000$4.98$49,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/20/2015Daniel BradburyDirectorSell10,000$5.32$53,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2015David L MahoneyDirectorSell33,828$5.74$194,172.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015James N WilsonDirectorSell10,000$6.06$60,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2015Daniel BradburyDirectorSell20,000$6.75$135,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2015Daniel BradburyDirectorSell10,000$6.92$69,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2015James N WilsonDirectorSell10,000$6.13$61,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/24/2015Patrick G EnrightDirectorSell1,089,745$5.75$6,266,033.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015Joseph C Cook JrDirectorSell77,200$5.22$402,984.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2014G Leonard Baker JrDirectorBuy103,386$2.32$239,855.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014Joseph Cook, Jr.DirectorBuy100,000$1.84$184,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2014Daniel BradburyDirectorBuy138,925$1.80$250,065.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2014G Leonard Baker, Jr.DirectorBuy100,000$1.84$184,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2014Longitude Venture Partners L.PDirectorSell250,000$4.11$1,027,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2014Patrick EnrightDirectorSell250,000$4.28$1,070,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2014Longitude Venture Partners L.PDirectorSell250,000$4.00$1,000,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2013Joseph L TurnerDirectorBuy10,000$2.01$20,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/5/2012G Leonard Baker JrDirectorBuy87,131$1.46$127,211.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/23/2012Daniel BradburyDirectorBuy179,000$1.39$248,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2012G Leonard Baker JrDirectorBuy300,000$1.83$549,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Corcept Therapeutics (NASDAQ:CORT)
DateHeadline
07/29/16 03:26 PMNew Broker Ratings For Corcept Therapeutics Incorporated (CORT) - FTSE News
07/26/16 03:05 PMCorcept Therapeutics to Announce Second Quarter 2016 Financial Results and Corporate Update and Host Conference Call - [Marketwired] - Corcept Therapeutics Incorporated today announced it will report second quarter financial results and provide a corporate update on August 2, 2016. The Company will also host a conference call that day ...
07/21/16 08:52 PMInsiders Increasing Positions in: Corcept Therapeutics Incorporated (NASDAQ:CORT) - Press Telegraph
07/21/16 03:28 PMEarnings Focus and Crowd Sourced Sentiment Review for Corcept Therapeutics Incorporated (NASDAQ:CORT) - TGP
07/20/16 04:31 PMCorcept Therapeutics Incorporated (CORT) Current Analyst Ratings - Fiscal Standard
07/19/16 08:42 PMCorcept Therapeutics Incorporated (NASDAQ:CORT): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/19/16 09:34 AMCorcept Therapeutics Incorporated (CORT) Broker Price Targets For The Coming Week - Fiscal Standard
07/14/16 03:34 PMInvestors Watch List: Cisco Systems, Inc. (NASDAQ:CSCO), Corcept Therapeutics Incorporated (NASDAQ:CORT ... - KC Register
07/14/16 11:22 AMEverybody's Doing It: 5 Stocks Under $10 That I Like -
07/14/16 07:42 AMCorcept Therapeutics Incorporated (NASDAQ:CORT) Shorted Shares Increased By 22.33% - Consumer Eagle
07/13/16 10:56 AMBroker Outlook For Corcept Therapeutics Incorporated (CORT) - Fiscal Standard
07/13/16 10:56 AMSentiment Change Report: Corcept Therapeutics Inc (NASDAQ:CORT) - Press Telegraph
07/10/16 03:11 PMNext Weeks Broker Price Targets For Corcept Therapeutics Incorporated (CORT) - Fiscal Standard
07/07/16 10:17 AMBrokers Issue Average Price Target Of 10.00 On Corcept Therapeutics Incorporated (CORT) - Fiscal Standard
07/04/16 03:08 PMShare Performance Recap for: Corcept Therapeutics Incorporated (NASDAQ:CORT) - Press Telegraph
06/30/16 08:48 PMRecently Issued Stock Ratings For Corcept Therapeutics Incorporated (CORT) - Fiscal Standard
06/29/16 08:30 AMZacks.com featured highlights: Arcos Dorados Holdings, Corcept Therapeutics, Exelixis, Hecla Mining and Lexington Realty Trust -
06/28/16 04:11 PMCorcept Therapeutics Appoints Renée D. Galá to Board of Directors - [at noodls] - Download this Press Release Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe ...
06/28/16 03:39 PMCORCEPT THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi -
06/28/16 03:20 PMCorcept Therapeutics Appoints Renee D. Gala to Board of Directors
06/28/16 08:14 AMShare Update and Earnings Review for Corcept Therapeutics Incorporated (NASDAQ:CORT) - Press Telegraph
06/27/16 03:21 PMEquity Research and Technical Review on Corcept Therapeutics Incorporated (NASDAQ:CORT) - Press Telegraph
06/27/16 09:28 AMCorcept Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CORT-US : June 27, 2016 -
06/27/16 07:52 AMReport Published: "Corcept Therapeutics Incorporated (CORT) - Financial and Strategic SWOT Analysis Review"
06/26/16 03:03 PMCorcept Therapeutics Incorporated (NASDAQ:CORT) Sellers Increased By 22.33% Their Shorts - Press Telegraph
06/26/16 03:03 PMCorcept Therapeutics Incorporated (NASDAQ:CORT) Yearly Sales Target At $1126.266 - Investor Newswire
06/22/16 03:31 PMCorcept Therapeutics Incorporated (NasdaqCM:CORT) Stock Momentum Hits Strength - CML News
06/22/16 03:31 PMCorcept Therapeutics Incorporated (CORT) Jumps 5.49% on June 20 - Equities.com
06/20/16 09:39 AMThis Weeks Broker Views For Corcept Therapeutics Incorporated (CORT) - Fiscal Standard
06/06/16 03:10 PMBroadwind Energy, Inc. (NASDAQ:BWEN) Declined -5.36%: Corcept Therapeutics Incorporated (NASDAQ:CORT ... - KC Register
06/06/16 06:16 AMPerformance Review for Corcept Therapeutics Incorporated (NASDAQ:CORT) - HNN
06/06/16 06:16 AMMost Recent Update on Price Moves: Intrexon (XON) , Corcept Therapeutics (CORT) - Street Updates
06/04/16 08:41 PMFBR & Co. Reiterates Buy Rating for Corcept Therapeutics Incorporated (CORT) - Let Me Know About This
06/04/16 11:51 AMWill Corcept Therapeutics Incorporated (NASDAQ:CORT) Surprise Analysts? - Investor Newswire
06/03/16 09:26 PMBuy, Sell Or Hold Rating For Corcept Therapeutics Incorporated (CORT)? - Share Trading News
06/03/16 04:06 PMCorcept (CORT) Reports Early Breast Cancer Data on Korlym -
06/03/16 11:49 AMTwo Breast Cancer Companies To Watch: Corcept Therapeutics Incorporated (NASDAQ:CORT) and Medivation Inc ... - Market Exclusive
06/02/16 09:23 PMCorcept Therapeutics (CORT) Announces Positive Prelim. Data from Mifepristone Phase 1/2 in TNBC; Efficacy Results ... - StreetInsider.com - SYS-CON MediaCorcept Therapeutics (CORT) Announces Positive Prelim. Data from Mifepristone Phase 1/2 in TNBC; Efficacy Results ...StreetInsider.comCorcept Therapeutics Incorporated , a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, psychiatric and oncologic disorders by modulating the effects of the stress hormone cortisol, ...Corcept Therapeutics Incorporated (CORT) - Broker UpdateRisers & Fallersall 3 news articles »
06/02/16 03:05 PMCorcept Therapeutics Provides Update of Progress in Cortisol Modulation Oncology Program - [Marketwired] - Corcept Therapeutics Incorporated
06/02/16 11:28 AMMoving Healthcare Focused Stocks: Pfizer, Inc. (NYSE:PFE) , Corcept Therapeutics Incorporated (NASDAQ:CORT) - Is stories - Moving Healthcare Focused Stocks: Pfizer, Inc. (NYSE:PFE) , Corcept Therapeutics Incorporated (NASDAQ:CORT)Is storiesIn most recently trading session on 6/1/2016, Corcept Therapeutics Incorporated (NASDAQ:CORT) climbed +1.18% while traded on 2.35 million shares versus it's an average volume of 265.35 thousand shares. The company recorded the last trade with the ...
06/01/16 11:48 AMEarnings Expectations Overview: Corcept Therapeutics Incorporated (NASDAQ:CORT), MDU Resources Group Inc ... - Beacon Chronicle - Beacon ChronicleEarnings Expectations Overview: Corcept Therapeutics Incorporated (NASDAQ:CORT), MDU Resources Group Inc ...Beacon ChronicleLast Trade: The Company closed its last session at $5.95 with the gain of 10.19%. The market capitalization of the company is $658.13 Million, with the average Volume of 230.07K. The stock currently has its 52-Week High range of $7.67 and 52-week low ...and more »
06/01/16 11:48 AMCorcept Therapeutics Incorporated (CORT) Jumps 10.19% on May 31 - Equities.com - Corcept Therapeutics Incorporated (CORT) Jumps 10.19% on May 31Equities.comCorcept Therapeutics Incorporated (CORT) was among the biggest gainers on the Russell 2000 for Tuesday May 31 as the stock popped 10.19% to $5.95, representing a gain of $0.55 per share. Some 1.33 million shares traded hands on 7,440 trades, ...Corcept Therapeutics Incorporated (CORT) Analyst ReviewRisers & FallersMarket Analyst's Checklist Stocks: Exelixis, Inc. (NASDAQ:EXEL), Corcept Therapeutics Incorporated (NASDAQ:CORT)WsNews 4investorsCorcept Therapeutics Incorporated (NASDAQ:CORT): Company Rating and Earnings RoundupFranklin IndependentHNN -Stock Tick Tockall 7 news articles »
05/31/16 03:22 PMCorcept Therapeutics Incorporated (NASDAQ:CORT)'s Company Shares Increased 13.21% After Low Volatility - HNN - Corcept Therapeutics Incorporated (NASDAQ:CORT)'s Company Shares Increased 13.21% After Low VolatilityHNNThe shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) increased by 13.21% in the last 20 days and rose 0.93% in the past 5 trading sessions. Corcept Therapeutics Incorporated (NASDAQ:CORT) shares opened at $5.42 in the last session and ...
05/30/16 09:33 PMStock Review and Earnings Check on Corcept Therapeutics Incorporated (NASDAQ:CORT) - HNN - Stock Review and Earnings Check on Corcept Therapeutics Incorporated (NASDAQ:CORT)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Corcept Therapeutics Incorporated (NASDAQ:CORT) to report quarterly EPS of $0.01. The company's next earnings report is expected to be ...and more »
05/30/16 09:33 PMStock Review and Earnings Check on Corcept Therapeutics Incorporated (NASDAQ:CORT) - HNN - Stock Review and Earnings Check on Corcept Therapeutics Incorporated (NASDAQ:CORT)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Corcept Therapeutics Incorporated (NASDAQ:CORT) to report quarterly EPS of $0.01. The company's next earnings report is expected to be ...and more »
05/26/16 08:54 PMInvestors Traded Stocks: Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) , Corcept Therapeutics Incorporated ... - Street Updates - Investors Traded Stocks: Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) , Corcept Therapeutics Incorporated ...Street UpdatesCorcept Therapeutics Incorporated (NASDAQ:CORT) unchanged +0.00 points or +0.00% to $5.48. The company has a market worth of $601.68M.Total 364.99 thousand shares were exchanged in last trading session as opposed to average volume of 210.65 ...and more »
05/26/16 06:27 AMInsiders Are Gradually Buying Corcept Therapeutics Incorporated (NASDAQ:CORT) - Wall Street Hints and News - Insiders Are Gradually Buying Corcept Therapeutics Incorporated (NASDAQ:CORT)Wall Street Hints and NewsAccording to the latest SEC filings, insiders at Corcept Therapeutics Incorporated (NASDAQ:CORT) have increased their position in the stock by 10.25% over the past 6 months. Insiders now own 0.70% of total outstanding shares. There are both legal and ...and more »
05/25/16 07:44 PMStock Rating Review for Corcept Therapeutics Incorporated (NASDAQ:CORT) - Wall Street Hints and News - Stock Rating Review for Corcept Therapeutics Incorporated (NASDAQ:CORT)Wall Street Hints and NewsInvestors may choose to follow the views of professional Wall Street analysts that regularly track the company. Covering equity analysts presently have a consensus stock rating of 1.75 on shares of Corcept Therapeutics Incorporated (NASDAQ:CORT).and more »
05/24/16 08:30 PMEarnings Review and Stock Rundown for Corcept Therapeutics Incorporated (NASDAQ:CORT) - Wall Street Hints and News - Earnings Review and Stock Rundown for Corcept Therapeutics Incorporated (NASDAQ:CORT)Wall Street Hints and NewsEarnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Corcept Therapeutics Incorporated (NASDAQ:CORT) to post quarterly EPS of $0.01. The company is expected to next publish earnings on or ...and more »
05/19/16 07:49 PMRevenue Update on Corcept Therapeutics Incorporated(NASDAQ:CORT) - Trade Calls - Revenue Update on Corcept Therapeutics Incorporated(NASDAQ:CORT)Trade CallsCorcept Therapeutics Incorporated(NASDAQ:CORT) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during After-hours on May 3, 2016. Company reported revenue of $16.06M. Analysts estimated a revenue of $16.59M.Corcept Therapeutics Incorporated (CORT) Updated Broker RatingsRisers & FallersCorcept Therapeutics Incorporated (NASDAQ:CORT) Short Interest Decreased By 3.56%Franklin Independentall 3 news articles »

Social

About Corcept Therapeutics

Corcept Therapeutics logoCorcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company's focus is on those disorders that are associated with a steroid hormone cortisol. Elevated levels and abnormal release patterns of cortisol have been implicated in a range of human disorders. The Company is developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive antagonist at the glucocorticoid receptor (GR). It has also discovered approximately three structurally distinct series of selective cortisol modulators, all of which share mifepristone's affinity for GR but, unlike mifepristone, do not bind to the progesterone receptor, and so do not terminate pregnancy or cause other side effects associated with progesterone receptor antagonism. It has begun pre-clinical and clinical development of its lead compounds from these series.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: CORT
  • CUSIP: 21835210
Key Metrics:
  • Previous Close: $5.80
  • 50 Day Moving Average: $5.64
  • 200 Day Moving Average: $4.77
  • P/E Ratio: N/A
  • P/E Growth: -1.28
  • Market Cap: $636.82M
  • Beta: 1.4
  • Current Year EPS Consensus Estimate: $0.04 EPS
  • Next Year EPS Consensus Estimate: $0.24 EPS
Additional Links:
Corcept Therapeutics (NASDAQ:CORT) Chart for Sunday, July, 31, 2016